Patents Represented by Attorney, Agent or Law Firm Douglas A. Petry
-
Patent number: 5561058Abstract: Methods are provided for the replication and amplification of RNA sequences by thermoactive DNA polymerases. In a preferred embodiment, high temperature reverse transcription is coupled to nucleic acid amplification in a one tube, one enzyme procedure using a thermostable DNA polymerase. Methods for eliminating carry over contamination of amplifications due to prior reverse transcription reactions are also provided. Reagents particularly suited for the methods of the present invention are provided.Type: GrantFiled: May 24, 1995Date of Patent: October 1, 1996Assignee: Hoffmann-La Roche Inc.Inventors: David H. Gelfand, Thomas W. Myers, Christopher L. Sigua
-
Patent number: 5550039Abstract: The present invention provides primers for the polymerase chain reaction amplification of a nucleic acid sequence encompassing the polymorphic regions of the second, third, and fourth exons of the HLA Class I B gene (HLA-B). The polymorphic regions of the second, third, and fourth exons of the HLA-B gene contain sufficient variability so that each allele is uniquely identified by the nucleic acid sequence within these regions. The primers and amplification methods of the present invention enable genotyping at the HLA-B locus using samples from a variety of sources and for detecting allelic variants not distinguishable by serological methods. The HLA-B DNA genotyping can be used for tissue typing, determining individual identity, and identifying disease susceptible individuals.Type: GrantFiled: March 7, 1995Date of Patent: August 27, 1996Assignee: Hoffmann-La Roche Inc.Inventor: Elizabeth A. Trachtenberg
-
Patent number: 5543296Abstract: Methods are provided for detecting carcinoma metastases in selected body tissues and fluids. These methods offer greater than 1,000-fold enhanced sensitivity compared to prior standard diagnostic methods. In one embodiment of the invention, target carcinoma associated nucleic acid sequences are identified for detecting minimal residual disease in lung carcinomas. The methods utilize nucleic acid amplification techniques, preferably, the polymerase chain reaction.Type: GrantFiled: December 16, 1994Date of Patent: August 6, 1996Assignees: Hoffman-La Roche Inc., Regents of the University of CaliforniaInventors: Robert E. Sobol, Mark R. Green, Ernest S. Kawasaki
-
Patent number: 5541065Abstract: A process for determining the genotype of an individual with respect to the alleles at the HLA DP locus involves obtaining a sample of nucleic acid from the individual, and hybridizing the nucleic acids with a panel of probes specific for variant segments of DPalpha and DPbeta genes. Because the variation between DPbeta alleles is highly dispersed throughout the second exon of the DPbeta gene, the discovery of many different DPbeta alleles makes the process far more discriminating and informative than cellular, RFLP, or serological methods. The process can also be carried out on amplified nucleic acid produced by the polymerase chain reaction using primers specific for the second exon of the DPalpha and DPbeta genes. HLA DP DNA typing methods are useful in the prevention of graft rejection and host versus graft disease, in determining susceptibility to autoimmune diseases, in providing evidence concerning the derivation from an individual of forensic samples, and in paternity testing.Type: GrantFiled: February 14, 1994Date of Patent: July 30, 1996Assignee: Hoffmann-La Roche Inc.Inventors: Henry A. Erlich, Glenn T. Horn, Teodorica Bugawan, Ann B. Begovich
-
Patent number: 5527898Abstract: The presence of human papillomavirus (HPV) in a sample can be detected and the HPV typed by a method that involves the amplification of HPV DNA sequences by the polymerase chain reaction (PCR). The primers used in the method are consensus primers that can be used to amplify a particular region of the genome of any HPV. The presence of HPV in a sample is indicated by the formation of amplified DNA. The HPV nucleic acid is detected by consensus probes that may be short oligonucleotide probes or long generic probes. The HPV is typed by the use of type-specific DNA probes specific for the amplified region of DNA.Type: GrantFiled: June 7, 1995Date of Patent: June 18, 1996Assignee: Hoffmann-La Roche Inc.Inventors: Heidi M. Bauer, Patti E. Gravitt, Catherine E. Greer, M. Michele Manos, Robert M. Resnick, Tracy Y. Zhang
-
Patent number: 5527669Abstract: Oligonucleotides primers can be used to amplify and detect Hepatitis C virus nucleic acids in a process that involves reverse transcription of the viral genomic RNA to create cDNA and the subsequent amplification of the cDNA by the polymerase chain reaction. Oligonucleotide probes can be used to detect the presence of amplified DNA by hybridization. The invention provides improved methods, compositions, and kits for amplifying and detecting U.S., Japan, and HCV-C prototype nucleic acids.Type: GrantFiled: May 10, 1994Date of Patent: June 18, 1996Assignee: Hoffmann-La Roche Inc.Inventors: Robert M. Resnick, Karen K. Y. Young
-
Patent number: 5512462Abstract: Methods and reagents are provided for the amplification of DNA sequences longer than 10 kilobases by the polymerase chain reaction (PCR). The methods use compositions consisting of a primary thermostable DNA polymerase from Thermus thermophilus combined with a lesser amount of a secondary thermostable DNA polymerase possessing a 3'-to-5' exonuclease activity from Thermococcus litoralis, Pyrococcus species GB-D or Thermotoga maritima. The DNA polymerase compositions, when used with the disclosed reaction buffer, enable amplifications of DNA sequences up to at least 42.2 kilobases in length.Type: GrantFiled: February 25, 1994Date of Patent: April 30, 1996Assignee: Hoffmann-La Roche Inc.Inventor: Suzanne Cheng
-
Patent number: 5508168Abstract: The present invention provides methods and reagents for the detection and identification of four causative agents of genital ulcerations, herpes simplex virus (HSV) types 1 and 2, Treponema pallidum, and Haemophilus ducreyi. The methods use sequence-specific primers which enable the simultaneous polymeric chain reaction amplification of genomic nucleic acid sequences from HSV types 1 and 2, T. pallidum, and H. ducreyi. Following amplification, sequence-specific oligonucleotide probes are used to detect and distinguish HSV type 1 and 2, T. pallidum, and H. ducreyi nucleic acid.Type: GrantFiled: May 16, 1994Date of Patent: April 16, 1996Assignee: Hoffmann-La Roche Inc.Inventors: Karina A. Orle, Judith B. Weiss
-
Patent number: 5491063Abstract: The present invention is directed to methods for controlling the light emission of an oligonucleotide labeled with a light-emitting label that are useful in nucleic acid detection assays. A reaction that results in the cleavage of single-stranded oligonucleotide probes labeled with a light-emitting label is carried out in the presence of a DNA binding compound that interacts with the label to modify the light emission of the label. The methods utilize the change in light emission of the labeled probe that results from degradation of the probe. The methods are applicable in general to assays that utilize a reaction that results in cleavage of oligonucleotide probes, and, in particular, to homogeneous amplification/detection assays wherein hybridized probe is cleaved concomitant with palmer extension. A homogeneous amplification/detection assay is provided which allows the simultaneous detection of the accumulation of amplified target and the sequence-specific detection of the target sequence.Type: GrantFiled: September 1, 1994Date of Patent: February 13, 1996Assignee: Hoffmann-La Roche Inc.Inventors: Mary E. Fisher, Robert M. Watson
-
Patent number: 5491225Abstract: This invention provides for superior nucleic acid primers for amplification of select target regions of the genome of the genus Legionella. The invention facilitates detection of pathogenic and nonpathogenic forms of this genus. The invention further provides for processes for using the primers in template dependent nucleic acid polymerase extension reactions to amplify select target regions. Kits for the use of these primers are also provided. This invention further provides for methods of controlling the intensity of visual signal for detection of duplex formation in nucleic acid hybridization assays under high stringent conditions. This method involves the blending of different capture probes onto a solid support.Type: GrantFiled: May 27, 1993Date of Patent: February 13, 1996Assignee: Hoffmann-La Roche Inc.Inventors: Teresa K. H. Picone, Theresa M. McCallum, Michael A. Zoccoli
-
Patent number: 5491086Abstract: Recombinant DNA sequences encoding the DNA polymerase activity of Pyrodictium species can be used to construct recombinant vectors and transformed host cells for production of the activity. Pyrodictium enzymes for catalyzing 3'.fwdarw.5' exonuclease activity, i.e., proofreading enzymes, are also provided. The Pyrodictium enzymes are useful in DNA amplification procedures and are not irreversibly inactivated by exposure to 100.degree. C. in a polymerase chain reaction.Type: GrantFiled: May 14, 1993Date of Patent: February 13, 1996Assignee: Hoffmann-La Roche Inc.Inventors: David H. Gelfand, Alice M. Wang
-
Patent number: 5468613Abstract: Single or multiple nucleotide variations in nucleic acid sequence can be detected in nucleic acids by a process whereby the sample suspected of containing the relevant nucleic acid is repeatedly treated with primers, nucleotide triphosphates, and an agent for polymerization of the triphosphates and then denatured, in a process which amplifies the sequence containing the nucleotide variation if it is present. In one embodiment, the sample is spotted on a membrane and treated with a labeled sequence-specific oligonucleotide probe. Hybridization of the probe to the sample is detected by the label on the probe.Type: GrantFiled: March 9, 1990Date of Patent: November 21, 1995Assignee: Hoffmann-La Roche Inc.Inventors: Henry A. Erlich, Glenn Horn, Randall K. Saiki, Kary B. Mullis
-
Patent number: 5451512Abstract: Primers for amplification of specific nucleic acid sequences of the second and third exon of HLA Class I A gene and probes for identifying polymorphic sequences contained in the amplified DNA can be used in processes for typing homozygous or heterozygous samples from a variety of sources and for detecting allelic variants not distinguishable by serological methods. This HLA-A DNA typing system can be used in a forward or reverse dot-blot format that is simple and rapid to perform, produces detectable signals in minutes, and can be used for tissue typing, determining individual identity, and identifying disease susceptible individuals.Type: GrantFiled: September 28, 1993Date of Patent: September 19, 1995Assignee: Hoffmann-La Roche Inc.Inventors: Raymond J. Apple, Teodorica L. Bugawan, Henry A. Erlich
-
Patent number: 5422242Abstract: Primers and probes can be used to detect nucleic acid from Mycobacterium in a sample and determine the species from which the nucleic acid originates. The primers amplify regions of the 16S ribosomal RNA gene and hybridize to regions conserved among species. Genus specific probes hybridize to sequences within the amplified region conserved among mycobacterial species, whereas the species specific probes hybridize to a variable region, so that the species identity can be uniquely determined. Consensus probes for detecting mycobacteria nucleic acids are provided which probes are not identical to any of the sequences of mycobacterial species.Type: GrantFiled: July 17, 1992Date of Patent: June 6, 1995Assignee: Hoffmann-La Roche Inc.Inventor: Karen K. Y. Young
-
Patent number: 5418149Abstract: Improved methods for amplifying nucleic acids can reduce non-specific amplification and minimize the effects of contamination of nucleic acid amplification reaction assays due to amplified product from previous amplifications. The methods involve the introduction of unconventional nucleotide bags into the amplification reaction products and treating the products by enzymatic (e.g., glycosylases) and/or physical-chemical means to render the product incapable of acting as a template for subsequent amplifications.Type: GrantFiled: January 5, 1993Date of Patent: May 23, 1995Assignee: Hoffmann-La Roche Inc.Inventors: David H. Gelfand, Shirley Y. Kwok, John J. Sninsky